Delivery Order SPE2DB20D1109-SPE2DB22FP59Y
Award Date 7/12/22
Potential Completion Date 7/13/22
Potential Value $4.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of MICARDIS HCT 80-12.5 MG TABLET UD 30S. The contract has a firm fixed price of $1,105.18 and a completion date of May 22, 2025. It is not set aside and represents an open competition award. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00,...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,217.60, is for the supply of MICARDIS HCT 80-25 mg tablet units with an ultimate completion date of March 13, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, in the amount of $1,328.12. The contract is for the supply of Micardis HCT 80-25 mg tablet units, a cardiovascular medication, to support military healthcare programs. The contract has a period of performance through May 13, 2024 and is a firm fixed-price delivery order. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,031.77, is for the delivery of MICARDIS HCT 80-25 MG TABLET UD 30S, a prescription medication. The contract has an ultimate completion date of November 13, 2023 and is a firm fixed-price delivery order. There is no set-aside designation indicated. AmerisourceBergen...
- This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,190.04 firm fixed-price contract is for the delivery of Micardis HCT 80-25 mg tablets, with a performance period ending on March 6, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,949.78, is for the delivery of MICARDIS HCT 40-12.5 MG TABLET UD 30S, a cardiovascular medication. The contract has an ultimate completion date of February 21, 2024 and is a Firm Fixed Price contract. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division, a major pharmaceutical distributor. The $1,645.38 firm fixed price contract is for the supply of Micardis HCT 80-25 mg tablets in 30-count units. The delivery order is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of medical...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Micardis HCT 80-12.5 mg tablets, a cardiovascular medication, valued at $4,209.48. The contract has an ultimate completion date of October 22, 2024 and is a firm fixed-price contract. This award is not associated with a set-aside program. AmerisourceBergen holds a significant...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,435.70, is for the delivery of Micardis HCT 40-12.5 mg tablets. The contract has a firm fixed price pricing type and an ultimate completion date of July 23, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,315.38 firm fixed-price delivery order is for the supply of MICARDIS HCT 80-25 MG TABLET UD 30S, a cardiovascular medication. The contract has an ultimate completion date of March 18, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB22FP59YDelivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4557775889 - MICARDIS HCT 80-25 MG TABLET UD 30S. The contract has a firm fixed price of $4,094.38 and an ultimate completion date of July 13, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order is not designated as a set-aside contract.
Generated 2/27/25, 10:19 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 7/12/22 |